| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.511 | 16.046 | 38.117 | 60.059 | 131.276 | 217.134 | 237.355 |
| Total Income - EUR | - | - | - | 8.385 | 24.030 | 42.909 | 64.998 | 137.084 | 222.960 | 251.003 |
| Total Expenses - EUR | - | - | - | 11.533 | 25.441 | 11.563 | 49.485 | 65.095 | 190.176 | 210.379 |
| Gross Profit/Loss - EUR | - | - | - | -3.148 | -1.411 | 31.346 | 15.513 | 71.989 | 32.785 | 40.624 |
| Net Profit/Loss - EUR | - | - | - | -3.213 | -1.596 | 30.178 | 13.602 | 68.248 | 30.874 | 34.718 |
| Employees | - | - | - | 2 | 0 | 0 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Aio Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 37.890 | 32.333 | 26.988 | 83.667 | 91.835 | 77.989 | 265.917 |
| Current Assets | - | - | - | 3.405 | 3.783 | 26.988 | 27.201 | 88.854 | 76.451 | 86.025 |
| Inventories | - | - | - | 2.471 | 0 | 0 | 0 | 59.439 | 62.672 | 24.339 |
| Receivables | - | - | - | 0 | 3.688 | 24.736 | 27.117 | 11.542 | 8.384 | 60.435 |
| Cash | - | - | - | 933 | 95 | 2.253 | 84 | 17.873 | 5.396 | 1.251 |
| Shareholders Funds | - | - | - | -3.180 | -4.715 | 25.552 | 38.588 | 106.992 | 137.541 | 171.491 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 77 | 77 | 76 |
| Debts | - | - | - | 4.756 | 7.336 | 296 | 49.403 | 55.390 | 36.063 | 211.881 |
| Income in Advance | - | - | - | 39.719 | 33.495 | 28.128 | 22.877 | 18.306 | 13.624 | 8.946 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Aio Pharma S.r.l.